Cargando…

SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease

SLC26A9 belongs to the solute carrier family 26 (SLC26), which comprises membrane proteins involved in ion transport mechanisms. On the basis of different preliminary findings, including the phenotype of SlC26A9-deficient mice and its possible role as a gene modifier of the human phenotype and treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorrieri, Giulia, Zara, Federico, Scudieri, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961553/
https://www.ncbi.nlm.nih.gov/pubmed/35204703
http://dx.doi.org/10.3390/biom12020202